Toronto – September 23, 2025 – The World Ovarian Cancer Coalition is proud to be one of 28 international partners in the newly launched DISARM Project, a major EU-funded initiative to tackle ovarian cancer. DISARM brings together world-class expertise to address one of the most urgent challenges in women’s health. Ovarian cancer is the most lethal of female cancers.
With €13.2 million in support, the DISARM project seeks to improve risk assessment and early detection of ovarian cancer. The World Ovarian Cancer Coalition’s CEO Clara MacKay, will represent the organisation at a two-day kick-off meeting in Athens in October 2025. “We are proud to stand alongside world-leading researchers, clinicians, and innovators in this important collaboration. By focusing on early detection and advanced risk assessment, DISARM has the potential to save lives and change the future of this disease.”
Coordinated by the Institute of Communication and Computer Systems (ICCS) in Greece, DISARM has four key pillars: ovarian cancer risk assessment, early detection, intelligent digital assets, and healthcare adoption strategies. By building international momentum, the project aims to close significant gaps in hereditary ovarian cancer management and set new standards for care.
DISARM brings together 28 partners from 12 countries including 10 EU Member States, the UK, and Canada. A Horizon Europe Innovation Action project, it is funded under the EU Mission on Cancer and was launched by the European Union, in coordination with the European Health and Digital Executive Agency (HADEA).
You can read more about the project here.
About the World Ovarian Cancer Coalition
The World Ovarian Cancer Coalition, the only global not-for-profit organization focused solely on ovarian cancer, was established in 2016 and comprises over 200 patient advocacy group members in 37 countries. We work globally to ensure that everyone living with, or at risk of, ovarian cancer has the best chance of survival and the best quality of life, no matter where they live. To learn more, visit our website and follow us on LinkedIn, Facebook, Instagram, X and YouTube.
Media contacts:
Annabel Deegan
media@worldovariancancercoalition.org
Helen Shik
Helen@worldovariancancercoalition.org